Explore European Union Legislation by Asking a Legal Question
assisted-checkbox
filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all
parameters-title
query
assisted-checkbox: ✅
result-title
total 2
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC article 29 CELEX: 02002L0098-20090807 Technical requirements and their adaptation to technical and scientific progress
The adaptation of the technical requirements set out in Annexes I to IV to technical and scientific progress shall be decided by the Commission. Those measures, designed to amend non-essential elements of this Directive by supplementing it, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 28(3). On imperative grounds of urgency, the Commission may have recourse to the urgency procedure referred to in Article 28(4) as regards technical requirements set out in Annexes III and IV.
The following technical requirements and their adaptation to technical and scientific progress shall be decided by the Commission: ◄
(a) traceability requirements; (b) information to be provided to donors; (c) information to be obtained from donors including the identification, health history, and the signature of the donor; (d) requirements concerning the suitability of blood and plasma donors and the screening of donated blood including — permanent deferral criteria and possible exemption thereto — temporary deferral criteria; |
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC article 29 CELEX: 02002L0098-20090807 (e) storage, transport and distribution requirements; (f) quality and safety requirements for blood and blood components; (g) requirements applicable to autologous transfusions; (h) Community standards and specifications relating to a quality system for blood establishments; (i) Community procedure for notifying serious adverse reactions and events and notification format.
Technical requirements referred to in points (a) to (i) of the second paragraph, being measures designed to amend non-essential elements of this Directive by supplementing it, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 28(3).
On imperative grounds of urgency the Commission may have recourse to the urgency procedure referred to in Article 28(4) as regards technical requirements referred to in points (b), (c),(d), (e), (f) and (g) of the second paragraph. |